| Combined nano-membrane technology for removal of lead ions I Hajdu, M Bodnár, Z Csikós, S Wei, L Daróczi, B Kovács, Z Győri, ... Journal of Membrane Science 409, 44-53, 2012 | 114 | 2012 |
| Self-assembling chitosan/poly-γ-glutamic acid nanoparticles for targeted drug delivery Z Keresztessy, M Bodnár, E Ber, I Hajdu, M Zhang, JF Hartmann, T Minko, ... Colloid and Polymer Science 287, 759-765, 2009 | 74 | 2009 |
| Nanoparticles prepared by self-assembly of chitosan and poly-γ-glutamic acid I Hajdu, M Bodnár, G Filipcsei, JF Hartmann, L Daróczi, M Zrínyi, ... Colloid and Polymer Science 286, 343-350, 2008 | 73 | 2008 |
| 99mTc-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities A Polyák, I Hajdu, M Bodnár, G Trencsényi, Z Pöstényi, V Haász, G Jánoki, ... International journal of pharmaceutics 449 (1-2), 10-17, 2013 | 49 | 2013 |
| Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific 68Ga-and 44Sc-labeled DOTA-NAPamide in melanoma imaging G Nagy, N Dénes, A Kis, JP Szabó, E Berényi, I Garai, P Bai, I Hajdu, ... European Journal of Pharmaceutical Sciences 106, 336-344, 2017 | 44 | 2017 |
| Synthesis of 68Ga-labeled biopolymer-based nanoparticle imaging agents for positron-emission tomography Z Körhegyi, D Rózsa, I Hajdu, M Bodnár, I Kertesz, K Kerekes, S Kun, ... Anticancer research 39 (5), 2415-2427, 2019 | 23 | 2019 |
| Folate receptor targeted self-assembled chitosan-based nanoparticles for SPECT/CT imaging: Demonstrating a preclinical proof of concept A Polyák, I Hajdu, M Bodnár, G Dabasi, RP Jóba, J Borbély, L Balogh International Journal of Pharmaceutics 474 (1-2), 91-94, 2014 | 22 | 2014 |
| Radiochemical synthesis and preclinical evaluation of 68Ga-labeled NODAGA-hydroxypropyl-beta-cyclodextrin (68Ga-NODAGA-HPBCD) I Hajdu, J Angyal, D Szikra, I Kertész, M Malanga, É Fenyvesi, L Szente, ... European Journal of Pharmaceutical Sciences 128, 202-208, 2019 | 19 | 2019 |
| Tumor-specific localization of self-assembled nanoparticle PET/MR modalities I Hajdu, G Trencsenyi, M Bodnar, M Emri, G Banfalvi, J Sikula, T Marian, ... Anticancer research 34 (1), 49-59, 2014 | 18 | 2014 |
| Cancer cell diagnosis by targeting delivery of nanodevices J Borbely, M Bodnar, JF Hartmann, I Hajdu, J Kollar, G Vamosi US Patent 7,976,825, 2011 | 15 | 2011 |
| Biopolymer-based nanosystem for ferric ion removal from water M Bodnár, I Hajdu, E Rőthi, N Harmati, Z Csikós, JF Hartmann, C Balogh, ... Separation and Purification Technology 112, 26-33, 2013 | 14 | 2013 |
| Cancer cell targeting and imaging with biopolymer-based nanodevices I Hajdu, M Bodnár, G Trencsényi, T Márián, G Vámosi, J Kollár, J Borbély International journal of pharmaceutics 441 (1-2), 234-241, 2013 | 14 | 2013 |
| Gemini surfactant-based systems for drug and gene delivery A Makhlouf, I Hajdu, I Badea Organic Materials as Smart Nanocarriers for Drug Delivery, 561-600, 2018 | 13 | 2018 |
| In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography G Trencsényi, A Kis, JP Szabó, Á Ráti, K Csige, É Fenyvesi, L Szente, ... International Journal of Pharmaceutics 576, 118954, 2020 | 10 | 2020 |
| A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior I Hajdu, A Makhlouf, VR Solomon, D Michel, M Al-Dulaymi, KM Wasan, ... International journal of nanomedicine, 7801-7818, 2018 | 9 | 2018 |
| Polymeric Nanoparticles by ion-ion interactions J Berbely, M Bodnar, I Hajdu, JF Hartmann, Z Keresztessy, L Nagy, ... US Patent App. 11/881,831, 2008 | 9 | 2008 |
| 111In-Labeled Glycoprotein Nonmetastatic b (GPNMB) Targeted Gemini Surfactant-Based Nanoparticles against Melanoma: In Vitro Characterization and in Vivo … A Makhlouf, I Hajdu, SV Hartimath, E Alizadeh, K Wharton, KM Wasan, ... Molecular Pharmaceutics 16 (2), 542-551, 2019 | 8 | 2019 |
| In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice K Csige, JP Szabó, I Kálmán-Szabó, NS Dénes, D Szikra, Z Képes, ... International Journal of Pharmaceutics 625, 122132, 2022 | 6 | 2022 |
| In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron … JP Szabó, K Csige, I Kálmán-Szabó, V Arató, G Opposits, I Jószai, ... International Journal of Pharmaceutics 630, 122462, 2023 | 5 | 2023 |
| In vivo preclinical assessment of novel 68Ga-labelled peptides for imaging of tumor associated angiogenesis using positron emission tomography imaging N Dénes, A Kis, JP Szabó, I Jószai, I Hajdu, V Arató, KN Enyedi, G Mező, ... Applied Radiation and Isotopes 174, 109778, 2021 | 5 | 2021 |
